{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:21Z","timestamp":1786118841441,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001929","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T06:39:52Z","timestamp":1446100792000},"page":"e1929","source":"Crossref","is-referenced-by-count":29,"title":["Prognosis of Early-Stage Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"94","author":[{"given":"Wei-Yu","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-75-20210226","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma.","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R2-75-20210226","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update.","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R3-75-20210226","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma.","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-75-20210226","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1665-2681(19)31365-1","article-title":"Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.","volume":"12","author":"Chen","year":"2013","journal-title":"Ann Hepatol"},{"key":"R5-75-20210226","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/jgh.12283","article-title":"Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.","volume":"28","author":"Su","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-75-20210226","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2011.05.026","article-title":"The changing scenario of hepatocellular carcinoma over the last two decades in Italy.","volume":"56","author":"Santi","year":"2012","journal-title":"J Hepatol"},{"key":"R7-75-20210226","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.24710","article-title":"Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.","volume":"55","author":"Altekruse","year":"2012","journal-title":"Hepatology"},{"key":"R8-75-20210226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajg.2011.425","article-title":"Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.","volume":"107","author":"Shiina","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R9-75-20210226","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","article-title":"Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.","volume":"58","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"R10-75-20210226","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/radiol.11110144","article-title":"Local-regional treatment of hepatocellular carcinoma.","volume":"262","author":"Lencioni","year":"2012","journal-title":"Radiology"},{"key":"R11-75-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0034-1394365","article-title":"Early hepatocellular carcinoma on the procrustean bed of ablation, resection, and transplantation.","volume":"34","author":"Mazzaferro","year":"2014","journal-title":"Semin Liver Dis"},{"key":"R12-75-20210226","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MCG.0b013e31822b36cc","article-title":"Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.","volume":"46","author":"Kao","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"R13-75-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archsurg.2011.288","article-title":"The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.","volume":"147","author":"Su","year":"2012","journal-title":"Arch Surg"},{"key":"R14-75-20210226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.25950","article-title":"Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.","volume":"57","author":"Hsu","year":"2013","journal-title":"Hepatology"},{"key":"R15-75-20210226","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s11605-012-2087-z","article-title":"Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.","volume":"17","author":"Hung","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"R16-75-20210226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.crad.2011.10.009","article-title":"Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.","volume":"67","author":"Kao","year":"2012","journal-title":"Clin Radiol"},{"key":"R17-75-20210226","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1097\/MD.0000000000000348","article-title":"A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.","volume":"93","author":"Hung","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"R18-75-20210226","first-page":"528","article-title":"Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.","volume":"23","author":"Kao","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R19-75-20210226","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MCG.0b013e31825ceeb5","article-title":"Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation.","volume":"46","author":"Wu","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"R20-75-20210226","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"R21-75-20210226","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2013.03.051","article-title":"A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.","volume":"145","author":"Nault","year":"2013","journal-title":"Gastroenterology"},{"key":"R22-75-20210226","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma.","volume":"359","author":"Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-75-20210226","doi-asserted-by":"crossref","first-page":"849874","DOI":"10.1155\/2012\/849874","article-title":"Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.","volume":"2012","author":"Calvisi","year":"2012","journal-title":"Mol Biol Int"},{"key":"R24-75-20210226","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","article-title":"Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.","volume":"9","author":"Hung","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-75-20210226","first-page":"809","article-title":"Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection S","volume":"152","author":"Chang","year":"2012","journal-title":"urgery"},{"key":"R26-75-20210226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification.","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R27-75-20210226","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.","volume":"41","author":"Marrero","year":"2005","journal-title":"Hepatology"},{"key":"R28-75-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/gut.2003.035055","article-title":"Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.","volume":"54","author":"Tateishi","year":"2005","journal-title":"Gut"},{"key":"R29-75-20210226","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"R30-75-20210226","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"R31-75-20210226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R32-75-20210226","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1245\/s10434-011-1551-4","article-title":"Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.","volume":"18","author":"DAvola","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R33-75-20210226","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","article-title":"Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.","volume":"62","author":"Vitale","year":"2015","journal-title":"J Hepatol"},{"key":"R34-75-20210226","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.","volume":"51","author":"Wu","year":"2009","journal-title":"J Hepatol"},{"key":"R35-75-20210226","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s00268-010-0928-z","article-title":"A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.","volume":"35","author":"Kao","year":"2011","journal-title":"World J Surg"},{"key":"R36-75-20210226","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12072-010-9213-3","article-title":"Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma.","volume":"4","author":"Hung","year":"2010","journal-title":"Hepatol Int"},{"key":"R37-75-20210226","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis.","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"R38-75-20210226","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2006.08.011","article-title":"Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.","volume":"4","author":"Giannini","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R39-75-20210226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"R40-75-20210226","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1478-3231.2012.02811.x","article-title":"Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naive patients with hepatocellular carcinoma.","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int"},{"key":"R41-75-20210226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/apt.12450","article-title":"Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.","volume":"38","author":"Tan","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-75-20210226","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"key":"R43-75-20210226","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","article-title":"Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey.","volume":"58","author":"Hasegawa","year":"2013","journal-title":"J Hepatol"},{"key":"R44-75-20210226","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASLAASLD recommendations: an observational study of the HCC East-West study group.","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"key":"R45-75-20210226","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jhep.2014.12.018","article-title":"Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis.","volume":"62","author":"Kluger","year":"2015","journal-title":"J Hepatol"},{"key":"R46-75-20210226","first-page":"922","article-title":"Is portal hypertension a contraindication to hepatic resection Ann S","volume":"250","author":"Cucchetti","year":"2009","journal-title":"urg"},{"key":"R47-75-20210226","doi-asserted-by":"crossref","first-page":"e112184","DOI":"10.1371\/journal.pone.0112184","article-title":"Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.","volume":"9","author":"Sinn","year":"2014","journal-title":"PLoS One"},{"key":"R48-75-20210226","doi-asserted-by":"crossref","first-page":"e66457","DOI":"10.1371\/journal.pone.0066457","article-title":"The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy.","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"R49-75-20210226","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1478-3231.2005.01081.x","article-title":"Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.","volume":"25","author":"Huang","year":"2005","journal-title":"Liver Int"},{"key":"R50-75-20210226","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.23221","article-title":"Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.","volume":"50","author":"Yang","year":"2009","journal-title":"Hepatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000001929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:55:39Z","timestamp":1786035339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201510270-00075"}},"subtitle":["The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":50,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001929","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}